| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Q Fever | 10 | 2023 | 37 | 4.860 |
Why?
|
| Coxiella burnetii | 9 | 2023 | 37 | 4.240 |
Why?
|
| Chemokine CXCL12 | 19 | 2023 | 464 | 3.930 |
Why?
|
| Islets of Langerhans Transplantation | 8 | 2023 | 744 | 2.490 |
Why?
|
| Bacterial Vaccines | 7 | 2022 | 403 | 2.220 |
Why?
|
| Receptors, CXCR4 | 9 | 2021 | 726 | 1.860 |
Why?
|
| Heterocyclic Compounds | 5 | 2019 | 249 | 1.840 |
Why?
|
| Alginates | 4 | 2023 | 252 | 1.450 |
Why?
|
| Chemotaxis, Leukocyte | 9 | 2010 | 675 | 1.410 |
Why?
|
| HSP70 Heat-Shock Proteins | 3 | 2018 | 404 | 1.330 |
Why?
|
| HIV Envelope Protein gp120 | 7 | 2011 | 952 | 1.300 |
Why?
|
| Vaccines | 5 | 2018 | 822 | 1.250 |
Why?
|
| Adjuvants, Immunologic | 5 | 2018 | 1001 | 1.140 |
Why?
|
| B-Lymphocytes | 9 | 2023 | 4665 | 1.120 |
Why?
|
| Islets of Langerhans | 2 | 2023 | 1350 | 1.100 |
Why?
|
| Skin | 8 | 2021 | 4363 | 1.030 |
Why?
|
| GPI-Linked Proteins | 2 | 2018 | 434 | 1.000 |
Why?
|
| T-Lymphocytes | 17 | 2022 | 10182 | 0.960 |
Why?
|
| Diabetes Mellitus, Experimental | 3 | 2020 | 1121 | 0.930 |
Why?
|
| Lasers | 3 | 2018 | 952 | 0.930 |
Why?
|
| Insulin-Secreting Cells | 3 | 2019 | 891 | 0.870 |
Why?
|
| Thymus Gland | 6 | 2007 | 1267 | 0.850 |
Why?
|
| Epitopes, T-Lymphocyte | 4 | 2022 | 880 | 0.840 |
Why?
|
| Influenza Vaccines | 5 | 2017 | 738 | 0.780 |
Why?
|
| Mesothelioma | 2 | 2018 | 818 | 0.710 |
Why?
|
| Benzylamines | 6 | 2020 | 226 | 0.700 |
Why?
|
| Cancer Vaccines | 3 | 2018 | 1024 | 0.690 |
Why?
|
| Drug Discovery | 3 | 2017 | 1058 | 0.670 |
Why?
|
| Ovarian Neoplasms | 4 | 2019 | 4837 | 0.660 |
Why?
|
| Wound Healing | 2 | 2021 | 2785 | 0.650 |
Why?
|
| Chemokines, CXC | 7 | 2007 | 422 | 0.640 |
Why?
|
| Immunity, Cellular | 3 | 2020 | 1607 | 0.630 |
Why?
|
| CD4-Positive T-Lymphocytes | 10 | 2019 | 4385 | 0.630 |
Why?
|
| Acquired Immunodeficiency Syndrome | 7 | 2008 | 2234 | 0.620 |
Why?
|
| Dendritic Cells | 8 | 2018 | 2725 | 0.600 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2021 | 571 | 0.600 |
Why?
|
| Infrared Rays | 3 | 2018 | 249 | 0.600 |
Why?
|
| Vaccination | 8 | 2022 | 3278 | 0.590 |
Why?
|
| Simian Acquired Immunodeficiency Syndrome | 3 | 2011 | 570 | 0.590 |
Why?
|
| Animals | 63 | 2023 | 168788 | 0.580 |
Why?
|
| HIV-1 | 15 | 2010 | 6938 | 0.570 |
Why?
|
| Hydroxychloroquine | 1 | 2020 | 412 | 0.550 |
Why?
|
| Simian immunodeficiency virus | 3 | 2011 | 846 | 0.550 |
Why?
|
| Tumor Microenvironment | 6 | 2022 | 3584 | 0.550 |
Why?
|
| Mice, Inbred C57BL | 20 | 2023 | 21824 | 0.540 |
Why?
|
| Diabetes Mellitus, Type 1 | 3 | 2019 | 3336 | 0.530 |
Why?
|
| Antigens, Bacterial | 2 | 2019 | 1171 | 0.530 |
Why?
|
| Immunomodulation | 2 | 2023 | 541 | 0.520 |
Why?
|
| Injections, Intradermal | 4 | 2018 | 117 | 0.520 |
Why?
|
| Mice | 37 | 2023 | 81178 | 0.490 |
Why?
|
| Avidin | 1 | 2014 | 44 | 0.480 |
Why?
|
| Graft Survival | 4 | 2023 | 3740 | 0.480 |
Why?
|
| Guinea Pigs | 3 | 2022 | 1386 | 0.470 |
Why?
|
| Regeneration | 2 | 2021 | 1485 | 0.470 |
Why?
|
| Chemotaxis | 5 | 2011 | 607 | 0.470 |
Why?
|
| Communicable Diseases, Emerging | 2 | 2014 | 157 | 0.470 |
Why?
|
| Lymphopoiesis | 2 | 2005 | 135 | 0.460 |
Why?
|
| Viral Vaccines | 2 | 2022 | 636 | 0.450 |
Why?
|
| Antigens, CD34 | 6 | 2001 | 657 | 0.450 |
Why?
|
| Immunity, Innate | 4 | 2023 | 2958 | 0.440 |
Why?
|
| Lassa Fever | 1 | 2014 | 97 | 0.440 |
Why?
|
| Interleukin-8 | 2 | 2005 | 690 | 0.430 |
Why?
|
| Flow Cytometry | 6 | 2017 | 5974 | 0.420 |
Why?
|
| Immunologic Memory | 1 | 2019 | 1348 | 0.410 |
Why?
|
| Wounds and Injuries | 2 | 2021 | 2400 | 0.410 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 2 | 2014 | 459 | 0.390 |
Why?
|
| Orthomyxoviridae Infections | 1 | 2013 | 248 | 0.390 |
Why?
|
| Immunocompetence | 1 | 2011 | 137 | 0.390 |
Why?
|
| Cytokines | 4 | 2023 | 7326 | 0.380 |
Why?
|
| Antibodies, Bacterial | 3 | 2022 | 1470 | 0.380 |
Why?
|
| Immune Tolerance | 2 | 2019 | 2258 | 0.380 |
Why?
|
| Stem Cells | 3 | 2021 | 3567 | 0.360 |
Why?
|
| Spleen | 3 | 2009 | 2361 | 0.360 |
Why?
|
| Influenza A virus | 1 | 2013 | 457 | 0.360 |
Why?
|
| Paclitaxel | 1 | 2017 | 1707 | 0.360 |
Why?
|
| Primates | 2 | 2023 | 544 | 0.360 |
Why?
|
| Brain Injuries | 1 | 2021 | 2025 | 0.350 |
Why?
|
| Biological Assay | 2 | 2010 | 652 | 0.340 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 2 | 2017 | 1039 | 0.330 |
Why?
|
| Skin Diseases | 1 | 2017 | 1065 | 0.330 |
Why?
|
| Gene Products, tat | 2 | 1999 | 120 | 0.330 |
Why?
|
| Lymph Nodes | 2 | 2011 | 3469 | 0.330 |
Why?
|
| HIV Antigens | 1 | 2009 | 347 | 0.320 |
Why?
|
| Signal Transduction | 11 | 2021 | 23404 | 0.310 |
Why?
|
| Organoids | 2 | 2007 | 700 | 0.310 |
Why?
|
| Neutrophils | 4 | 2015 | 3717 | 0.300 |
Why?
|
| Antibodies, Viral | 4 | 2022 | 3176 | 0.290 |
Why?
|
| Interferon-gamma | 4 | 2021 | 3203 | 0.290 |
Why?
|
| Immunophenotyping | 5 | 2021 | 1880 | 0.280 |
Why?
|
| Humans | 92 | 2023 | 744220 | 0.280 |
Why?
|
| Neoplasm Proteins | 1 | 2019 | 3703 | 0.280 |
Why?
|
| Cell Migration Inhibition | 1 | 2006 | 96 | 0.280 |
Why?
|
| T-Lymphocytes, Regulatory | 2 | 2011 | 2988 | 0.280 |
Why?
|
| Monocytes | 5 | 2020 | 2594 | 0.270 |
Why?
|
| Receptors, Interleukin-8B | 1 | 2005 | 59 | 0.270 |
Why?
|
| Drug Approval | 1 | 2012 | 741 | 0.270 |
Why?
|
| AIDS-Related Opportunistic Infections | 3 | 2001 | 657 | 0.250 |
Why?
|
| Disease Models, Animal | 7 | 2022 | 18027 | 0.250 |
Why?
|
| Viral Envelope Proteins | 1 | 2008 | 635 | 0.250 |
Why?
|
| Diabetes Mellitus | 1 | 2023 | 5755 | 0.250 |
Why?
|
| HIV Infections | 13 | 2020 | 16718 | 0.250 |
Why?
|
| Pilot Projects | 3 | 2023 | 8321 | 0.240 |
Why?
|
| Hematopoietic Stem Cells | 6 | 2005 | 3385 | 0.240 |
Why?
|
| Ovalbumin | 3 | 2014 | 719 | 0.240 |
Why?
|
| Seroepidemiologic Studies | 2 | 2022 | 402 | 0.240 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 4 | 2020 | 3871 | 0.240 |
Why?
|
| Transplantation, Heterologous | 3 | 2023 | 2382 | 0.240 |
Why?
|
| Zoonoses | 2 | 2021 | 185 | 0.230 |
Why?
|
| Immune System | 2 | 2008 | 805 | 0.230 |
Why?
|
| Drug Synergism | 2 | 2018 | 1791 | 0.230 |
Why?
|
| Mice, Transgenic | 4 | 2020 | 9735 | 0.220 |
Why?
|
| Antibodies, Neutralizing | 3 | 2022 | 1978 | 0.220 |
Why?
|
| CD8-Positive T-Lymphocytes | 6 | 2022 | 4477 | 0.220 |
Why?
|
| Melanoma, Experimental | 1 | 2006 | 561 | 0.210 |
Why?
|
| Immunization | 3 | 2019 | 1256 | 0.210 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2012 | 2038 | 0.210 |
Why?
|
| Mice, Inbred BALB C | 3 | 2020 | 6386 | 0.210 |
Why?
|
| Cricetulus | 2 | 2018 | 817 | 0.210 |
Why?
|
| Forkhead Transcription Factors | 1 | 2009 | 1613 | 0.210 |
Why?
|
| Enzyme-Linked Immunospot Assay | 2 | 2019 | 130 | 0.210 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3132 | 0.210 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3239 | 0.200 |
Why?
|
| Tissue Array Analysis | 2 | 2017 | 553 | 0.200 |
Why?
|
| Australia | 2 | 2022 | 1169 | 0.200 |
Why?
|
| Antibody Formation | 2 | 2021 | 1402 | 0.200 |
Why?
|
| Capsules | 2 | 2021 | 197 | 0.200 |
Why?
|
| Chemotactic Factors | 2 | 2015 | 199 | 0.200 |
Why?
|
| Cell Line, Tumor | 7 | 2019 | 16687 | 0.200 |
Why?
|
| CHO Cells | 2 | 2018 | 1407 | 0.190 |
Why?
|
| Epitopes | 2 | 2022 | 2571 | 0.190 |
Why?
|
| Female | 34 | 2021 | 380197 | 0.190 |
Why?
|
| Virus Replication | 3 | 1999 | 2534 | 0.190 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 3 | 2020 | 11493 | 0.190 |
Why?
|
| Models, Immunological | 1 | 2003 | 527 | 0.180 |
Why?
|
| Societies, Scientific | 1 | 2021 | 220 | 0.180 |
Why?
|
| Bacterial Proteins | 1 | 2014 | 3849 | 0.180 |
Why?
|
| Cricetinae | 2 | 2018 | 2472 | 0.180 |
Why?
|
| Pertussis Toxin | 3 | 2005 | 178 | 0.180 |
Why?
|
| Cell Movement | 5 | 2018 | 5216 | 0.180 |
Why?
|
| Immunity, Humoral | 2 | 2022 | 598 | 0.180 |
Why?
|
| Immunotherapy | 3 | 2021 | 4440 | 0.180 |
Why?
|
| Leukocytes | 1 | 2008 | 2040 | 0.180 |
Why?
|
| Asparagine | 2 | 1989 | 122 | 0.180 |
Why?
|
| Interleukin-10 | 2 | 2023 | 1200 | 0.180 |
Why?
|
| Membrane Glycoproteins | 2 | 2008 | 3769 | 0.170 |
Why?
|
| HIV Seroprevalence | 2 | 1996 | 86 | 0.170 |
Why?
|
| Hematopoietic Cell Growth Factors | 1 | 1999 | 102 | 0.170 |
Why?
|
| Neoplasms | 6 | 2022 | 21672 | 0.170 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2005 | 828 | 0.170 |
Why?
|
| Chondrosarcoma | 1 | 2021 | 309 | 0.170 |
Why?
|
| Tumor Necrosis Factor-alpha | 4 | 2023 | 4419 | 0.160 |
Why?
|
| HLA-DR Antigens | 1 | 2020 | 645 | 0.160 |
Why?
|
| Receptors, CXCR | 1 | 2018 | 52 | 0.160 |
Why?
|
| Antigens, CD | 3 | 2011 | 4026 | 0.160 |
Why?
|
| Toll-Like Receptors | 1 | 2021 | 592 | 0.160 |
Why?
|
| Artificial Organs | 1 | 2000 | 204 | 0.160 |
Why?
|
| Papillomavirus Infections | 1 | 2009 | 1587 | 0.150 |
Why?
|
| Complement C3 | 2 | 1989 | 461 | 0.150 |
Why?
|
| Still's Disease, Adult-Onset | 1 | 2017 | 19 | 0.150 |
Why?
|
| Administration, Intranasal | 1 | 2018 | 446 | 0.150 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2018 | 3772 | 0.150 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2009 | 2019 | 0.150 |
Why?
|
| Aspartic Acid | 2 | 1989 | 576 | 0.150 |
Why?
|
| Injections, Subcutaneous | 1 | 2018 | 665 | 0.150 |
Why?
|
| Lasers, Semiconductor | 1 | 2017 | 46 | 0.150 |
Why?
|
| Mucous Membrane | 2 | 2011 | 668 | 0.150 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 2 | 2015 | 222 | 0.150 |
Why?
|
| Cell Growth Processes | 1 | 2017 | 400 | 0.140 |
Why?
|
| T-Lymphocytes, Cytotoxic | 4 | 2018 | 1821 | 0.140 |
Why?
|
| Swine | 3 | 2023 | 5940 | 0.140 |
Why?
|
| Macaca mulatta | 4 | 2011 | 2378 | 0.140 |
Why?
|
| Tissue Engineering | 1 | 2007 | 1880 | 0.140 |
Why?
|
| Neuroprotective Agents | 1 | 2023 | 941 | 0.140 |
Why?
|
| Receptors, CCR5 | 2 | 2011 | 497 | 0.140 |
Why?
|
| Insulin | 3 | 2021 | 6583 | 0.140 |
Why?
|
| Hospital Units | 1 | 1997 | 141 | 0.140 |
Why?
|
| Maximum Tolerated Dose | 1 | 2018 | 892 | 0.140 |
Why?
|
| Genomic Instability | 1 | 2020 | 695 | 0.130 |
Why?
|
| Pneumonia, Pneumocystis | 1 | 1997 | 249 | 0.130 |
Why?
|
| Hexuronic Acids | 1 | 2015 | 144 | 0.130 |
Why?
|
| Glucuronic Acid | 1 | 2015 | 148 | 0.130 |
Why?
|
| Cells, Cultured | 8 | 2018 | 19227 | 0.130 |
Why?
|
| Peptides | 3 | 2022 | 4407 | 0.130 |
Why?
|
| Lymphoma, AIDS-Related | 1 | 1995 | 84 | 0.130 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2017 | 10949 | 0.120 |
Why?
|
| Cell Proliferation | 6 | 2018 | 10480 | 0.120 |
Why?
|
| Coculture Techniques | 4 | 2009 | 1341 | 0.120 |
Why?
|
| Antibody Specificity | 2 | 2020 | 1095 | 0.120 |
Why?
|
| Anti-HIV Agents | 5 | 2020 | 4256 | 0.120 |
Why?
|
| HLA-DR3 Antigen | 1 | 2014 | 34 | 0.120 |
Why?
|
| Aspergillus fumigatus | 1 | 2015 | 150 | 0.120 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2017 | 731 | 0.120 |
Why?
|
| Ferritins | 1 | 2017 | 590 | 0.120 |
Why?
|
| Systems Biology | 1 | 2017 | 469 | 0.120 |
Why?
|
| Sequence Analysis, RNA | 2 | 2022 | 2013 | 0.120 |
Why?
|
| Liver Neoplasms | 2 | 2021 | 4252 | 0.120 |
Why?
|
| HIV Antibodies | 2 | 1998 | 1322 | 0.110 |
Why?
|
| Cell Death | 2 | 2011 | 1708 | 0.110 |
Why?
|
| Hypersensitivity | 1 | 2022 | 1102 | 0.110 |
Why?
|
| Methylprednisolone | 2 | 1985 | 388 | 0.110 |
Why?
|
| HIV-2 | 1 | 1994 | 167 | 0.110 |
Why?
|
| HLA Antigens | 1 | 2019 | 1382 | 0.110 |
Why?
|
| Lassa virus | 1 | 2014 | 97 | 0.110 |
Why?
|
| AIDS Vaccines | 2 | 2010 | 938 | 0.110 |
Why?
|
| Russia | 1 | 2014 | 408 | 0.110 |
Why?
|
| London | 4 | 1997 | 233 | 0.110 |
Why?
|
| Hematopoiesis | 2 | 2005 | 2069 | 0.110 |
Why?
|
| Antigens | 1 | 2018 | 1466 | 0.110 |
Why?
|
| Fetus | 4 | 2005 | 1880 | 0.110 |
Why?
|
| Mast Cells | 2 | 2018 | 1544 | 0.110 |
Why?
|
| Inflammation | 4 | 2010 | 10634 | 0.110 |
Why?
|
| Genetic Vectors | 4 | 1998 | 3420 | 0.110 |
Why?
|
| Osteosarcoma | 1 | 2018 | 881 | 0.110 |
Why?
|
| Antigen Presentation | 2 | 2009 | 1284 | 0.110 |
Why?
|
| Chronic Disease | 4 | 2019 | 9147 | 0.100 |
Why?
|
| Mouth Neoplasms | 1 | 2017 | 601 | 0.100 |
Why?
|
| Point-of-Care Systems | 1 | 2020 | 1176 | 0.100 |
Why?
|
| HIV Seropositivity | 2 | 1995 | 971 | 0.100 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2000 | 1838 | 0.100 |
Why?
|
| Laser Therapy | 1 | 2018 | 1072 | 0.100 |
Why?
|
| DNA, Viral | 3 | 1999 | 2226 | 0.100 |
Why?
|
| Interleukin-1 | 1 | 2015 | 1263 | 0.100 |
Why?
|
| Microscopy, Confocal | 1 | 2017 | 1971 | 0.100 |
Why?
|
| Killer Cells, Natural | 1 | 2020 | 2133 | 0.100 |
Why?
|
| Mice, Knockout | 3 | 2021 | 14556 | 0.100 |
Why?
|
| Gene Products, gag | 2 | 2011 | 337 | 0.100 |
Why?
|
| Defective Viruses | 1 | 1991 | 112 | 0.100 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 1997 | 810 | 0.100 |
Why?
|
| High-Throughput Screening Assays | 1 | 2017 | 945 | 0.100 |
Why?
|
| Genes, env | 1 | 2010 | 95 | 0.090 |
Why?
|
| Lung Neoplasms | 2 | 2018 | 13096 | 0.090 |
Why?
|
| Male | 21 | 2021 | 350027 | 0.090 |
Why?
|
| Protein Engineering | 1 | 2014 | 540 | 0.090 |
Why?
|
| Bone Marrow Transplantation | 2 | 2009 | 2763 | 0.090 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2021 | 1836 | 0.090 |
Why?
|
| Peritoneal Cavity | 1 | 2010 | 148 | 0.090 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2012 | 546 | 0.090 |
Why?
|
| Fluorescent Dyes | 1 | 2017 | 1917 | 0.090 |
Why?
|
| Cholesterol Ester Storage Disease | 1 | 1989 | 2 | 0.090 |
Why?
|
| Stem Cell Transplantation | 1 | 2018 | 1620 | 0.090 |
Why?
|
| Sterol Esterase | 1 | 1989 | 37 | 0.090 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2021 | 2214 | 0.090 |
Why?
|
| Antibodies | 1 | 2017 | 2461 | 0.090 |
Why?
|
| Chemokine CCL5 | 1 | 2009 | 209 | 0.080 |
Why?
|
| Vaccines, Synthetic | 2 | 2022 | 634 | 0.080 |
Why?
|
| Transforming Growth Factor beta | 3 | 2023 | 2008 | 0.080 |
Why?
|
| Mesentery | 1 | 2010 | 205 | 0.080 |
Why?
|
| Interleukin-6 | 3 | 2023 | 3201 | 0.080 |
Why?
|
| Cell Division | 5 | 1999 | 4567 | 0.080 |
Why?
|
| Carboxylic Ester Hydrolases | 1 | 1989 | 98 | 0.080 |
Why?
|
| Recovery of Function | 1 | 2019 | 2925 | 0.080 |
Why?
|
| tat Gene Products, Human Immunodeficiency Virus | 2 | 1999 | 127 | 0.080 |
Why?
|
| Survival Rate | 4 | 2011 | 12781 | 0.080 |
Why?
|
| Cell Survival | 2 | 2017 | 5881 | 0.080 |
Why?
|
| Acute Kidney Injury | 1 | 2021 | 1971 | 0.080 |
Why?
|
| Cell Communication | 2 | 2008 | 1621 | 0.080 |
Why?
|
| Emergency Service, Hospital | 3 | 1997 | 7659 | 0.080 |
Why?
|
| Chickens | 1 | 2010 | 865 | 0.080 |
Why?
|
| Data Interpretation, Statistical | 1 | 2017 | 2715 | 0.080 |
Why?
|
| Adoptive Transfer | 1 | 2010 | 844 | 0.070 |
Why?
|
| Single-Cell Analysis | 1 | 2017 | 2183 | 0.070 |
Why?
|
| Lymphoid Tissue | 1 | 2008 | 455 | 0.070 |
Why?
|
| Acute Disease | 1 | 2017 | 7148 | 0.070 |
Why?
|
| Heart | 1 | 2020 | 4465 | 0.070 |
Why?
|
| Liver | 2 | 2005 | 7472 | 0.070 |
Why?
|
| Receptors, Calcium-Sensing | 2 | 2005 | 315 | 0.070 |
Why?
|
| Molecular Sequence Data | 5 | 2010 | 18116 | 0.070 |
Why?
|
| Vaginal Smears | 1 | 2009 | 511 | 0.070 |
Why?
|
| Recombinant Proteins | 2 | 2014 | 6612 | 0.070 |
Why?
|
| Gene Knockdown Techniques | 1 | 2011 | 1655 | 0.070 |
Why?
|
| Transplantation, Homologous | 1 | 2015 | 4776 | 0.070 |
Why?
|
| Peroxidase | 1 | 2009 | 611 | 0.070 |
Why?
|
| Self Tolerance | 1 | 2007 | 125 | 0.070 |
Why?
|
| Polymerase Chain Reaction | 4 | 2010 | 6172 | 0.070 |
Why?
|
| Alkaline Phosphatase | 1 | 2009 | 865 | 0.070 |
Why?
|
| Phenotype | 3 | 2021 | 16365 | 0.070 |
Why?
|
| Interleukin-2 | 2 | 2023 | 1904 | 0.070 |
Why?
|
| Combined Modality Therapy | 1 | 2018 | 8628 | 0.070 |
Why?
|
| Antigen-Presenting Cells | 1 | 2009 | 973 | 0.070 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2006 | 370 | 0.070 |
Why?
|
| Apoptosis | 3 | 2011 | 9728 | 0.070 |
Why?
|
| Biopsy | 1 | 2017 | 6757 | 0.070 |
Why?
|
| In Situ Hybridization | 1 | 2009 | 1950 | 0.070 |
Why?
|
| Cell Line | 5 | 2007 | 15999 | 0.070 |
Why?
|
| Receptors, Antigen, T-Cell | 2 | 2006 | 2540 | 0.060 |
Why?
|
| Pseudopodia | 1 | 2005 | 172 | 0.060 |
Why?
|
| Cell Separation | 3 | 2001 | 1751 | 0.060 |
Why?
|
| Antiretroviral Therapy, Highly Active | 2 | 2012 | 1873 | 0.060 |
Why?
|
| Breast Neoplasms | 1 | 2012 | 20817 | 0.060 |
Why?
|
| Myocardium | 2 | 2009 | 4776 | 0.060 |
Why?
|
| Epigenesis, Genetic | 1 | 2018 | 3646 | 0.060 |
Why?
|
| Transgenes | 2 | 1999 | 1009 | 0.060 |
Why?
|
| Adult | 15 | 2022 | 214035 | 0.060 |
Why?
|
| Cell Culture Techniques | 3 | 2004 | 1677 | 0.060 |
Why?
|
| Endothelium, Vascular | 2 | 2009 | 4455 | 0.060 |
Why?
|
| Blood Glucose | 1 | 2019 | 6259 | 0.060 |
Why?
|
| Time Factors | 6 | 2011 | 40063 | 0.060 |
Why?
|
| Cytotoxicity Tests, Immunologic | 1 | 2004 | 329 | 0.060 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2005 | 293 | 0.060 |
Why?
|
| Myocardial Contraction | 1 | 2009 | 1585 | 0.060 |
Why?
|
| Proviruses | 2 | 1999 | 318 | 0.060 |
Why?
|
| Middle Aged | 12 | 2021 | 213367 | 0.060 |
Why?
|
| Equipment Design | 2 | 2017 | 3582 | 0.060 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2011 | 1221 | 0.060 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2020 | 9960 | 0.060 |
Why?
|
| Papillomaviridae | 1 | 2009 | 1119 | 0.060 |
Why?
|
| Disease-Free Survival | 1 | 2014 | 6893 | 0.060 |
Why?
|
| Rats | 3 | 2010 | 24273 | 0.060 |
Why?
|
| Cytoskeleton | 2 | 2005 | 1185 | 0.060 |
Why?
|
| Organ Culture Techniques | 1 | 2005 | 813 | 0.060 |
Why?
|
| Histamine | 2 | 2004 | 507 | 0.060 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2014 | 1832 | 0.050 |
Why?
|
| Isoantibodies | 1 | 2007 | 681 | 0.050 |
Why?
|
| Macrophages | 1 | 2017 | 5657 | 0.050 |
Why?
|
| Genes, Reporter | 1 | 2007 | 1547 | 0.050 |
Why?
|
| Genetic Engineering | 2 | 2007 | 952 | 0.050 |
Why?
|
| Transfection | 1 | 1991 | 5892 | 0.050 |
Why?
|
| Gene Transfer Techniques | 2 | 1998 | 1224 | 0.050 |
Why?
|
| Cell Polarity | 1 | 2005 | 645 | 0.050 |
Why?
|
| RNA Interference | 1 | 2011 | 2890 | 0.050 |
Why?
|
| Multiple Myeloma | 1 | 2020 | 5180 | 0.050 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2006 | 1368 | 0.050 |
Why?
|
| Stress, Physiological | 1 | 2009 | 1404 | 0.050 |
Why?
|
| Clinical Competence | 2 | 2001 | 4687 | 0.050 |
Why?
|
| Survival Analysis | 2 | 2014 | 10250 | 0.050 |
Why?
|
| ADP-ribosyl Cyclase | 1 | 2001 | 38 | 0.050 |
Why?
|
| Cyclic AMP | 1 | 2005 | 1471 | 0.050 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2017 | 4033 | 0.050 |
Why?
|
| Blotting, Western | 1 | 2009 | 5180 | 0.050 |
Why?
|
| Immunoglobulin G | 3 | 2022 | 4559 | 0.050 |
Why?
|
| Base Sequence | 4 | 1999 | 12801 | 0.050 |
Why?
|
| Epithelial Cells | 1 | 2014 | 3690 | 0.050 |
Why?
|
| NAD+ Nucleosidase | 1 | 2001 | 39 | 0.050 |
Why?
|
| Gene Expression Profiling | 1 | 2017 | 9438 | 0.050 |
Why?
|
| Cell Adhesion | 1 | 2008 | 3144 | 0.050 |
Why?
|
| Chemokine CXCL10 | 1 | 2022 | 304 | 0.050 |
Why?
|
| Enzymes | 1 | 1983 | 266 | 0.050 |
Why?
|
| Integrins | 1 | 2005 | 846 | 0.050 |
Why?
|
| Immunohistochemistry | 2 | 2017 | 11368 | 0.050 |
Why?
|
| Treatment Outcome | 5 | 2018 | 63119 | 0.050 |
Why?
|
| Protein Kinase C | 1 | 2005 | 1227 | 0.050 |
Why?
|
| Diffusion Chambers, Culture | 1 | 2000 | 50 | 0.050 |
Why?
|
| Catalysis | 1 | 2022 | 761 | 0.050 |
Why?
|
| Asparaginase | 1 | 1982 | 235 | 0.050 |
Why?
|
| Antineoplastic Agents | 2 | 2020 | 13668 | 0.050 |
Why?
|
| Amino Acid Sequence | 2 | 2009 | 13817 | 0.050 |
Why?
|
| Gene Expression | 2 | 2019 | 7799 | 0.050 |
Why?
|
| Cell Differentiation | 5 | 2018 | 11478 | 0.050 |
Why?
|
| Virulence Factors, Bordetella | 1 | 2000 | 156 | 0.050 |
Why?
|
| Organ Specificity | 2 | 2005 | 2007 | 0.050 |
Why?
|
| Receptors, CCR2 | 2 | 2017 | 212 | 0.050 |
Why?
|
| Liposomes | 1 | 2004 | 758 | 0.050 |
Why?
|
| Clinical Trials, Phase I as Topic | 1 | 2021 | 323 | 0.050 |
Why?
|
| Warts | 1 | 2020 | 68 | 0.050 |
Why?
|
| United States | 2 | 2021 | 69867 | 0.050 |
Why?
|
| Disease Progression | 3 | 2010 | 13280 | 0.050 |
Why?
|
| Microscopy, Electron, Scanning | 2 | 2000 | 964 | 0.050 |
Why?
|
| Lymphocyte Count | 1 | 2022 | 793 | 0.050 |
Why?
|
| Axons | 1 | 2008 | 1686 | 0.040 |
Why?
|
| Pandemics | 1 | 2020 | 8387 | 0.040 |
Why?
|
| Bone Marrow Cells | 3 | 2006 | 2513 | 0.040 |
Why?
|
| Cord Blood Stem Cell Transplantation | 1 | 2002 | 314 | 0.040 |
Why?
|
| Culture Techniques | 1 | 2000 | 554 | 0.040 |
Why?
|
| Graft Rejection | 2 | 2020 | 4399 | 0.040 |
Why?
|
| Convalescence | 1 | 2019 | 105 | 0.040 |
Why?
|
| Leukocyte Count | 3 | 1991 | 1584 | 0.040 |
Why?
|
| Drug Contamination | 1 | 2020 | 148 | 0.040 |
Why?
|
| Clinical Trials, Phase II as Topic | 1 | 2021 | 628 | 0.040 |
Why?
|
| Stroke | 1 | 2021 | 9981 | 0.040 |
Why?
|
| Polymorphism, Genetic | 1 | 1989 | 4328 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2009 | 8302 | 0.040 |
Why?
|
| Myeloid Cells | 1 | 2023 | 809 | 0.040 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2000 | 319 | 0.040 |
Why?
|
| Antigens, Differentiation | 1 | 2001 | 927 | 0.040 |
Why?
|
| CD40 Ligand | 1 | 2020 | 526 | 0.040 |
Why?
|
| Leukemia Virus, Murine | 1 | 1998 | 117 | 0.040 |
Why?
|
| Injury Severity Score | 1 | 2021 | 1013 | 0.040 |
Why?
|
| Histocompatibility Testing | 1 | 2019 | 742 | 0.040 |
Why?
|
| Cell Transformation, Viral | 1 | 1999 | 565 | 0.040 |
Why?
|
| Pancreas Transplantation | 1 | 2018 | 188 | 0.040 |
Why?
|
| Young Adult | 3 | 2018 | 56436 | 0.040 |
Why?
|
| Adolescent | 4 | 2018 | 85759 | 0.040 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2006 | 1269 | 0.040 |
Why?
|
| Mannose-Binding Lectins | 1 | 2017 | 100 | 0.040 |
Why?
|
| Clonal Anergy | 1 | 2017 | 169 | 0.040 |
Why?
|
| Immunoassay | 1 | 2020 | 752 | 0.040 |
Why?
|
| Ventricular Function, Left | 1 | 2009 | 3669 | 0.040 |
Why?
|
| Peptide Fragments | 1 | 2009 | 5096 | 0.040 |
Why?
|
| Zebrafish | 1 | 2008 | 2994 | 0.040 |
Why?
|
| HIV Protease Inhibitors | 1 | 1999 | 430 | 0.040 |
Why?
|
| Carbon | 1 | 2000 | 687 | 0.040 |
Why?
|
| Stromal Cells | 1 | 2002 | 1355 | 0.040 |
Why?
|
| Cell Lineage | 2 | 2009 | 2504 | 0.030 |
Why?
|
| Transduction, Genetic | 1 | 1999 | 913 | 0.030 |
Why?
|
| Asthma | 2 | 1985 | 6011 | 0.030 |
Why?
|
| Membranes, Artificial | 2 | 1976 | 378 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2021 | 1731 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2005 | 2938 | 0.030 |
Why?
|
| Immunoglobulin M | 1 | 2020 | 1538 | 0.030 |
Why?
|
| Cats | 1 | 1997 | 998 | 0.030 |
Why?
|
| Myocardial Ischemia | 1 | 2006 | 2148 | 0.030 |
Why?
|
| Hospitals, Urban | 1 | 1997 | 499 | 0.030 |
Why?
|
| Retrospective Studies | 7 | 2022 | 77426 | 0.030 |
Why?
|
| Mice, Inbred NOD | 1 | 2020 | 1877 | 0.030 |
Why?
|
| Retroviridae | 1 | 1998 | 914 | 0.030 |
Why?
|
| DNA Primers | 1 | 1999 | 2892 | 0.030 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2019 | 1475 | 0.030 |
Why?
|
| Cell Count | 1 | 1999 | 1854 | 0.030 |
Why?
|
| Bone and Bones | 1 | 2005 | 2575 | 0.030 |
Why?
|
| Microglia | 1 | 2023 | 1266 | 0.030 |
Why?
|
| AIDS Serodiagnosis | 1 | 1995 | 184 | 0.030 |
Why?
|
| Phosphatidylcholines | 1 | 1976 | 411 | 0.030 |
Why?
|
| Equipment Failure Analysis | 1 | 2017 | 868 | 0.030 |
Why?
|
| Transients and Migrants | 1 | 1996 | 155 | 0.030 |
Why?
|
| Lectins, C-Type | 1 | 2017 | 588 | 0.030 |
Why?
|
| Congresses as Topic | 1 | 2018 | 764 | 0.030 |
Why?
|
| Patient Admission | 1 | 2001 | 1380 | 0.030 |
Why?
|
| Adaptive Immunity | 1 | 2018 | 713 | 0.030 |
Why?
|
| Truth Disclosure | 1 | 1997 | 436 | 0.030 |
Why?
|
| ROC Curve | 1 | 2021 | 3527 | 0.030 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2019 | 1366 | 0.030 |
Why?
|
| Antigens, Surface | 1 | 2017 | 1663 | 0.030 |
Why?
|
| Bacterial Infections | 1 | 2001 | 1401 | 0.030 |
Why?
|
| Arthralgia | 1 | 2017 | 456 | 0.030 |
Why?
|
| Glycoproteins | 1 | 2000 | 2263 | 0.030 |
Why?
|
| Exanthema | 1 | 2017 | 501 | 0.030 |
Why?
|
| Prednisone | 1 | 2017 | 1575 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 1999 | 4752 | 0.030 |
Why?
|
| Lymphocyte Activation | 1 | 2003 | 5523 | 0.030 |
Why?
|
| Colonic Neoplasms | 1 | 2004 | 2538 | 0.030 |
Why?
|
| HEK293 Cells | 1 | 2021 | 4201 | 0.030 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2017 | 541 | 0.020 |
Why?
|
| Models, Biological | 1 | 2008 | 9582 | 0.020 |
Why?
|
| Pancreas | 1 | 2018 | 1686 | 0.020 |
Why?
|
| Pluripotent Stem Cells | 1 | 2018 | 795 | 0.020 |
Why?
|
| AIDS-Related Complex | 1 | 1991 | 111 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2018 | 2078 | 0.020 |
Why?
|
| Lab-On-A-Chip Devices | 1 | 2015 | 428 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2020 | 6461 | 0.020 |
Why?
|
| Receptors, Cell Surface | 1 | 2000 | 2867 | 0.020 |
Why?
|
| Hospitals, General | 1 | 1995 | 749 | 0.020 |
Why?
|
| Abdominal Pain | 1 | 2017 | 1062 | 0.020 |
Why?
|
| Blotting, Southern | 1 | 1991 | 803 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2017 | 2700 | 0.020 |
Why?
|
| Bone Marrow | 1 | 2000 | 2944 | 0.020 |
Why?
|
| Albumins | 2 | 1983 | 569 | 0.020 |
Why?
|
| Viral Proteins | 1 | 1997 | 1900 | 0.020 |
Why?
|
| HIV | 1 | 1997 | 1604 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 2021 | 3591 | 0.020 |
Why?
|
| Fever | 1 | 2017 | 1614 | 0.020 |
Why?
|
| Boston | 2 | 2018 | 9311 | 0.020 |
Why?
|
| Aged | 4 | 2019 | 163253 | 0.020 |
Why?
|
| Drug Resistance | 2 | 1985 | 1608 | 0.020 |
Why?
|
| Tissue Donors | 1 | 2018 | 2242 | 0.020 |
Why?
|
| Ribonuclease, Pancreatic | 1 | 1989 | 154 | 0.020 |
Why?
|
| Neoplastic Stem Cells | 1 | 2017 | 1376 | 0.020 |
Why?
|
| Urban Population | 1 | 1996 | 2021 | 0.020 |
Why?
|
| Critical Illness | 1 | 2021 | 2670 | 0.020 |
Why?
|
| Autoimmune Diseases | 1 | 2020 | 2136 | 0.020 |
Why?
|
| Myocardial Infarction | 1 | 2009 | 11728 | 0.020 |
Why?
|
| Deficiency Diseases | 1 | 1968 | 72 | 0.020 |
Why?
|
| Catalase | 1 | 1968 | 222 | 0.020 |
Why?
|
| Intensive Care Units | 1 | 2021 | 3680 | 0.020 |
Why?
|
| Length of Stay | 1 | 2021 | 6308 | 0.020 |
Why?
|
| Massachusetts | 1 | 2020 | 8663 | 0.020 |
Why?
|
| Oligonucleotides | 1 | 1991 | 572 | 0.020 |
Why?
|
| Codon | 1 | 1989 | 611 | 0.020 |
Why?
|
| Glucocorticoids | 1 | 2017 | 2108 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2022 | 13036 | 0.020 |
Why?
|
| Apolipoproteins B | 1 | 1989 | 374 | 0.020 |
Why?
|
| Mouth Mucosa | 1 | 2010 | 434 | 0.020 |
Why?
|
| Creatine Kinase, BB Form | 1 | 2006 | 7 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2010 | 1724 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1989 | 1801 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2020 | 12244 | 0.020 |
Why?
|
| Calcium | 1 | 2000 | 5757 | 0.020 |
Why?
|
| Cholesterol | 1 | 1976 | 2911 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2017 | 6535 | 0.020 |
Why?
|
| Histamine Release | 1 | 1986 | 142 | 0.020 |
Why?
|
| Hospitals | 1 | 2020 | 3952 | 0.020 |
Why?
|
| Receptors, LDL | 1 | 1989 | 475 | 0.020 |
Why?
|
| Caseins | 1 | 2006 | 103 | 0.020 |
Why?
|
| Creatine Kinase, MB Form | 1 | 2006 | 214 | 0.020 |
Why?
|
| Plasmids | 1 | 1991 | 2307 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2009 | 774 | 0.020 |
Why?
|
| Hybrid Cells | 1 | 1985 | 441 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2020 | 14726 | 0.020 |
Why?
|
| Rectum | 1 | 2010 | 904 | 0.020 |
Why?
|
| Polymers | 2 | 1983 | 1620 | 0.020 |
Why?
|
| Antibodies, Anti-Idiotypic | 1 | 1986 | 349 | 0.020 |
Why?
|
| Receptor, Insulin | 1 | 1989 | 846 | 0.020 |
Why?
|
| Vagina | 1 | 2010 | 825 | 0.020 |
Why?
|
| Colony-Forming Units Assay | 1 | 1984 | 354 | 0.020 |
Why?
|
| Referral and Consultation | 1 | 1997 | 3528 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 1991 | 1782 | 0.020 |
Why?
|
| Pancreatic Neoplasms | 1 | 1982 | 5257 | 0.010 |
Why?
|
| Aging | 1 | 2003 | 8661 | 0.010 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2010 | 2559 | 0.010 |
Why?
|
| Lysosomes | 1 | 1989 | 893 | 0.010 |
Why?
|
| Prednisolone | 1 | 1984 | 334 | 0.010 |
Why?
|
| Synovial Membrane | 1 | 1986 | 507 | 0.010 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 1 | 2006 | 493 | 0.010 |
Why?
|
| Enzyme Therapy | 1 | 1983 | 9 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2021 | 21752 | 0.010 |
Why?
|
| Lymphokines | 1 | 1986 | 949 | 0.010 |
Why?
|
| Chemistry, Physical | 1 | 1983 | 156 | 0.010 |
Why?
|
| Disease Susceptibility | 1 | 2010 | 1782 | 0.010 |
Why?
|
| Physicians | 1 | 2001 | 4564 | 0.010 |
Why?
|
| Chemical Phenomena | 1 | 1983 | 518 | 0.010 |
Why?
|
| Lymphocytes | 1 | 1991 | 2617 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2010 | 35423 | 0.010 |
Why?
|
| Brain Neoplasms | 1 | 2004 | 8860 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 1998 | 4935 | 0.010 |
Why?
|
| Culture Media, Conditioned | 1 | 2004 | 534 | 0.010 |
Why?
|
| Sarcoma, Experimental | 1 | 1982 | 128 | 0.010 |
Why?
|
| RNA, Viral | 1 | 1991 | 2902 | 0.010 |
Why?
|
| Biotransformation | 1 | 1982 | 169 | 0.010 |
Why?
|
| Cell Membrane Permeability | 1 | 2004 | 590 | 0.010 |
Why?
|
| Algorithms | 1 | 2022 | 13885 | 0.010 |
Why?
|
| Clone Cells | 1 | 1985 | 1692 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2017 | 12961 | 0.010 |
Why?
|
| Evolution, Molecular | 1 | 2010 | 1939 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2019 | 7179 | 0.010 |
Why?
|
| Transplantation, Autologous | 1 | 2006 | 2124 | 0.010 |
Why?
|
| Viral Load | 1 | 2010 | 3300 | 0.010 |
Why?
|
| Hydrogels | 1 | 2006 | 724 | 0.010 |
Why?
|
| Collagen Type I | 1 | 2004 | 592 | 0.010 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2006 | 986 | 0.010 |
Why?
|
| Lymphocyte Depletion | 1 | 2002 | 608 | 0.010 |
Why?
|
| Immunoglobulin E | 1 | 1986 | 1463 | 0.010 |
Why?
|
| Lectins | 1 | 1983 | 513 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 25043 | 0.010 |
Why?
|
| Risk Factors | 2 | 2017 | 72280 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2021 | 23337 | 0.010 |
Why?
|
| Saquinavir | 1 | 1999 | 28 | 0.010 |
Why?
|
| Prevalence | 1 | 1996 | 15226 | 0.010 |
Why?
|
| Peptide Hydrolases | 1 | 1983 | 633 | 0.010 |
Why?
|
| Cell Membrane | 2 | 1982 | 3748 | 0.010 |
Why?
|
| Indinavir | 1 | 1999 | 74 | 0.010 |
Why?
|
| RNA | 1 | 1989 | 2749 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2017 | 12718 | 0.010 |
Why?
|
| Intestinal Mucosa | 1 | 2010 | 3036 | 0.010 |
Why?
|
| Prospective Studies | 2 | 2021 | 53280 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 1997 | 12075 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 1996 | 15538 | 0.010 |
Why?
|
| Fibroblasts | 1 | 1989 | 4156 | 0.010 |
Why?
|
| Community Health Centers | 1 | 2001 | 428 | 0.010 |
Why?
|
| Moloney murine leukemia virus | 1 | 1998 | 139 | 0.010 |
Why?
|
| Lac Operon | 1 | 1998 | 238 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2006 | 2967 | 0.010 |
Why?
|
| Cattle | 1 | 2004 | 3922 | 0.010 |
Why?
|
| Mutation | 2 | 2021 | 29784 | 0.010 |
Why?
|
| Blood Proteins | 1 | 1983 | 1123 | 0.010 |
Why?
|
| Ritonavir | 1 | 1999 | 322 | 0.010 |
Why?
|
| Receptors, Chemokine | 1 | 2000 | 669 | 0.010 |
Why?
|
| Cytosol | 1 | 2000 | 901 | 0.010 |
Why?
|
| beta-Galactosidase | 1 | 1998 | 573 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2009 | 5982 | 0.010 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2006 | 2267 | 0.010 |
Why?
|
| Palmitates | 1 | 1976 | 74 | 0.010 |
Why?
|
| Culture Media | 1 | 1998 | 908 | 0.010 |
Why?
|
| Ligands | 1 | 1983 | 3294 | 0.010 |
Why?
|
| Calcium Signaling | 1 | 2000 | 721 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2018 | 40992 | 0.010 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 1998 | 625 | 0.010 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2006 | 2072 | 0.010 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 1982 | 1380 | 0.010 |
Why?
|
| HLA-D Antigens | 1 | 1991 | 134 | 0.010 |
Why?
|
| HIV Core Protein p24 | 1 | 1991 | 256 | 0.010 |
Why?
|
| Viral Core Proteins | 1 | 1991 | 162 | 0.010 |
Why?
|
| Arthritis, Rheumatoid | 1 | 1986 | 3712 | 0.010 |
Why?
|
| Child | 1 | 2018 | 77679 | 0.010 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 1998 | 2014 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 1994 | 57768 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 1999 | 6485 | 0.010 |
Why?
|
| Borates | 1 | 1968 | 21 | 0.010 |
Why?
|
| Injections, Intraperitoneal | 1 | 1968 | 424 | 0.000 |
Why?
|
| Histocytochemistry | 1 | 1968 | 719 | 0.000 |
Why?
|
| p-Methoxy-N-methylphenethylamine | 1 | 1986 | 41 | 0.000 |
Why?
|
| Calcimycin | 1 | 1986 | 222 | 0.000 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2001 | 3923 | 0.000 |
Why?
|
| Erythrocytes | 1 | 1976 | 2454 | 0.000 |
Why?
|
| Antibodies, Monoclonal | 1 | 1982 | 9275 | 0.000 |
Why?
|
| Postoperative Complications | 1 | 2006 | 15294 | 0.000 |
Why?
|
| Microscopy, Electron | 1 | 1986 | 2645 | 0.000 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1986 | 2505 | 0.000 |
Why?
|
| Internship and Residency | 1 | 2001 | 5787 | 0.000 |
Why?
|
| Osteoarthritis | 1 | 1986 | 1036 | 0.000 |
Why?
|
| Cohort Studies | 1 | 2001 | 40559 | 0.000 |
Why?
|